Can anyone with a research background interpret this?
My understanding is that they have showed statistical significance at the 5% confidence interval but not at the 2.5% interval. Does anyone know if this is sufficient for ARTG registration? They’ve said it supports commercialisation pathway so I’m assuming it does.
If so, game changing result…
Ann: Schedule 3 CBD trial preliminary results, page-2
Add BOD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.256M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| BOD (ASX) Chart |
Day chart unavailable